About the Authors
- Maria R. Sorensen
-
Contributed equally to this work with: Maria R. Sorensen, Sara R. Pedersen
Affiliation Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
- Sara R. Pedersen
-
Contributed equally to this work with: Maria R. Sorensen, Sara R. Pedersen
Affiliation Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
- Annika Lindkvist
-
Affiliation Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
- Jan P. Christensen
-
Affiliation Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
- Allan R. Thomsen
-
* E-mail: athomsen@sund.ku.dk
Affiliation Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
Competing Interests
The authors have read the journal's policy and have the following conflicts: The authors, Jan P. Christensen and Allan R. Thomsen, together with Peter J. Holst and the University of Copenhagen hold a patent regarding the invariant chain vaccine strategy. The authors declare their financial interest in the result as a consequence of their interest in the following patent: PCT/DK20006000675, A nucleotide vaccine. The authors should like to state that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: MRS ART. Performed the experiments: MRS SRP AL. Analyzed the data: MRS SRP AL JPC ART. Contributed reagents/materials/analysis tools: JPC. Wrote the paper: MRS SRP JPC ART.